+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

Vascular endothelial growth factor A inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Vascular endothelial growth factor A inhibitors - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
mTORC-1 Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

mTORC-1 Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Apoptosis Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Apoptosis Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Sphingosine 1-Phosphate (S1P) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Sphingosine 1-Phosphate (S1P) Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Enhancer of zeste homolog 2 (EZH2) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Enhancer of zeste homolog 2 (EZH2) Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Caspases Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Caspases Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
From
Anaplastic lymphoma kinase inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Anaplastic lymphoma kinase inhibitors - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Beta-3 Receptors Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

Beta-3 Receptors Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Cyclin-Dependent Kinase 9 (CDK9) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Cyclin-Dependent Kinase 9 (CDK9) Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 90 Pages
  • Global
From
mTORC-2 Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

mTORC-2 Inhibitor - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Retinoic acid receptor agonists - Pipeline Insight, 2024 - Product Thumbnail Image

Retinoic acid receptor agonists - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
TGF-Beta Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

TGF-Beta Inhibitor - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
TGF-Beta-2 Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

TGF-Beta-2 Inhibitor - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
From
Caspase 3 (CPP32, Apopain or YAMA) Activators - Pipeline Insight, 2024 - Product Thumbnail Image

Caspase 3 (CPP32, Apopain or YAMA) Activators - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Anti-Mucin 1 (MUC1) Antibody - Pipeline Insight, 2024 - Product Thumbnail Image

Anti-Mucin 1 (MUC1) Antibody - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Anti-Lymphotoxin - Pipeline Insight, 2024 - Product Thumbnail Image

Anti-Lymphotoxin - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Anti-Dickkopf-1 (Dkk-1) Antibody - Pipeline Insight, 2024 - Product Thumbnail Image

Anti-Dickkopf-1 (Dkk-1) Antibody - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Anti-CD80 Antibody - Pipeline Insight, 2024 - Product Thumbnail Image

Anti-CD80 Antibody - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more